A. D. Ho

Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program

Peter McLaughlin, A.J. Grillo-López, Brian K. Link et al. · Journal of Clinical Oncology · 2023 · 120 citations

Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1.

Mei Yu, Mark C. Leavitt, M Maruyama et al. · Proceedings of the National Academy of Sciences · 1995 · 103 citations · Full text

Viral Replication, Cell Therapy, Human Retrovirus +15

Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both.

A. D. Ho, D.J. Young, M Maruyama et al. · PubMed · 1996 · 67 citations

Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: preclinical studies

X Li, Alain Gervaix, David E. Kang et al. · Gene Therapy · 1998 · 34 citations · Full text

Primary Immunodeficiency, Gene Therapies, Cell Therapy +12

Sequential studies on the role of mitoxantrone in the treatment of acute leukaemia

H. G. Prentice, Gregory K. Robbins, Daiqiang Ma et al. · Cancer Treatment Reviews · 1983 · 30 citations

Hematological Malignancy, Acute Leukaemia, Oncology +8